Transdermal Delivery of Adipocyte Phospholipase A2 siRNA using Microneedles to Treat Thyroid Associated Ophthalmopathy-Related Proptosis

Guiqin Liu,Yan Deng,Yi Song,Yi Sui,Juan Cen,Ziyu Shao,Hu Li,Tao Tang

DOI: https://doi.org/10.1177/09636897211010633

2021-01-01

Cell Transplantation

Abstract:Thyroid associated ophthalmopathy (TAO) is an organ-specific autoimmune disease occurring in patients with thyroid disease. Patients with TAO-related proptosis is largely due to excessive orbital adipose tissue Adipocyte phospholipase A2 (AdPLA) is one of the most important regulatory factors in adipocyte lipolysis, which may be associated with TAO-related proptosis. Thus, silencing AdPLA by RNA interference may be beneficial for the treatment of TAO. In this study, we sought to evaluate the efficiency of two types of microneedles to deliver siRNAs for silencing AdPLA. Our results showed that AdPLA mRNA was up-regulated in the orbit adipose tissues from TAO patients. Silence of AdPLA by siRNA can reduce lipid accumulation in both human and mouse adipocyte cell lines. Moreover, silence effects of silicon microneedle array patch-based and injectable microneedle device-based siRNA administration were examined at the belly site of the mice, and injectable microneedle device showed higher knockdown efficiency than silicon microneedle array patch. This study sets the stage not only for future treatment of TAO-related proptosis using AdPLA siRNA, but also provides the foundation for targeted siRNA delivery by using microneedles.

medicine, research & experimental,transplantation,cell & tissue engineering

What problem does this paper attempt to address?

The problem that this paper attempts to solve is proptosis related to Thyroid Associated Ophthalmopathy (TAO). Specifically, the paper focuses on treating TAO - related proptosis by using microneedle technology to deliver small interfering RNA (siRNA) targeting adipocyte phospholipase A2 (AdPLA) to reduce the excessive accumulation of adipose tissue in the orbit of TAO patients. TAO is an organ - specific autoimmune disease related to thyroid diseases. Approximately 52% of TAO patients' proptosis is caused by excessive adipose tissue in the orbit. AdPLA is an important regulator in the adipocyte lipolysis process and may be related to TAO - related proptosis. Therefore, silencing the AdPLA gene through RNA interference technology may be beneficial for the treatment of TAO. In the paper, the researchers evaluated the efficiency of two types of microneedles in delivering siRNA to silence AdPLA and found that the injection - type microneedle device had a better knockdown effect in mice than the silicon microneedle array patch. This not only lays the foundation for the future use of AdPLA siRNA to treat TAO - related proptosis, but also provides a theoretical basis for targeted siRNA delivery using microneedles.

Transdermal Delivery of Adipocyte Phospholipase A2 siRNA using Microneedles to Treat Thyroid Associated Ophthalmopathy-Related Proptosis

Transdermal Delivery of siRNA through Microneedle Array

Local Administration of Sirna Through Microneedle: Optimization, Bio-distribution, Tumor Suppression and Toxicity

Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models

Identification of differentially expressed long non-coding RNAs and mRNAs in orbital adipose/connective tissue of thyroid-associated ophthalmopathy

Differentially Expressed Circular RNAs in Orbital Adipose/connective Tissue from Patients with Thyroid-Associated Ophthalmopathy.

Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia

Reduction-responsive Polymeric Micelles for Trans-Corneal Targeted Delivery of Microrna-21-5p and Glaucoma-Specific Gene Therapy.

Transcriptomic Profiling of Thyroid Eye Disease Orbital Fat Demonstrates Differences in Adipogenicity and IGF-1R Pathway

Therapeutic Silence of Pleiotrophin by Targeted Delivery of Sirna and Its Effect on the Inhibition of Tumor Growth and Metastasis

Noninvasive Delivery of Oligonucleotide by Penetratin-Modified Polyplexes to Inhibit Protein Expression of Intraocular Tumor

MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy

Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy

In Vitro Investigation of HIF-1α as a Therapeutic Target for Thyroid-Associated Ophthalmopathy

Ionic liquid combined with cationic liposome co-delivers microphthalmia-associated transcription factor small interfering RNA to regulate melanogenesis

[Research status of potential therapeutic targets for thyroid-associated ophthalmopathy]

Intraocular Sirna Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene

Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy.

Antisense oligonucleotide and thyroid hormone conjugates for obesity treatment

Efficient Delivery of siRNA via Tetrahedral Framework Nucleic Acids: Inflammation Attenuation and Matrix Regeneration in Temporomandibular Joint Osteoarthritis

Adipose/Connective Tissue From Thyroid-Associated Ophthalmopathy Uncovers Interdependence Between Methylation and Disease Pathogenesis: A Genome-Wide Methylation Analysis